Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Egle Ramelyte, Gaetana Restivo, Maria Mannino, Mitchell P Levesque & Reinhard Dummer. (2022) Advances in the drug management of basal cell carcinoma. Expert Opinion on Pharmacotherapy 23:5, pages 573-582.
Read now
Read now
Articles from other publishers (5)
Rifat R. Saytburkhanov, Alexey A. Kubanov, Irina N. Kondrakhina & Xenia I. Plakhova. (2023) Molecular markers of recurrence of basal cell skin cancer. Vestnik dermatologii i venerologii 98:6, pages 39-47.
Crossref
Crossref
Yijing Jiang, Jie Zhang, Conglin Shi, Xingjuan Li, Yongying Jiang & Renfang Mao. (2023)
NF-
κ
B: a mediator that promotes or inhibits angiogenesis in human diseases?
. Expert Reviews in Molecular Medicine 25.
Crossref
Crossref
Olivia M. Chen, Keemberly Kim, Chelsea Steele, Kelly M. Wilmas, Nader Aboul-Fettouh, Carrick Burns, Hung Quoc Doan, Sirunya Silapunt & Michael R. Migden. (2022) Advances in Management and Therapeutics of Cutaneous Basal Cell Carcinoma. Cancers 14:15, pages 3720.
Crossref
Crossref
Anna M. Czarnecka & Karolina Stachyra. 2021. New Therapies in Advanced Cutaneous Malignancies. New Therapies in Advanced Cutaneous Malignancies
57
97
.
Yong Liu, Hui Liu & Queqiao Bian. (2020) Identification of Potential Biomarkers Associated with Basal Cell Carcinoma. BioMed Research International 2020, pages 1-10.
Crossref
Crossref